FDA issues prescription drug promotion guidance; FDA approves first follow-on biologic of Lilly’s Humalog; drugmakers allegedly hired nurses to promote drugs
Five things for pharma marketers to know: Monday, December 11, 2017
Pfizer’s Viagra generic to sell for half the price; GSK seeks oncology deals; Ionis’ experimental Huntington’s drug tackles toxic protein for the first time
Horizon CEO Tim Walbert knows patients because he is one
August 23, 2017
11:00 am
He was diagnosed years ago with a handful of autoimmune conditions, treating them with drugs like Abbvie’s Humira, which he helped commercialize.
Five things for pharma marketers to know: Monday, August 21, 2017
August 21, 2017
2:18 pm
The FDA approves Ironwood’s gout drug; GSW names new president; Samsung and Takeda to partner on biologic development
Five things for pharma marketers to know: Wednesday, June 14, 2017
Sanofi to boost investment in biologics R&D; Sage’s awareness campaign criticized; PatientsLikeMe poll finds 95% of patients want some costs of drugs covered
Five things for pharma marketers to know: Tuesday, May 16, 2017
Eli Lilly and Boehringer Ingelheim received approval to begin selling their Lantus knock-off drug after settling a patent lawsuit with Sanofi in September.
Five things for pharma marketers to know: Thursday, December 17, 2015